Clinical evaluation of proton pump inhibitor, rabeprazole - Special surveillance in patients of advanced age with peptic ulcer diseases

Japanese Pharmacology and Therapeutics

Volumn 30, Issue 7, 2002, Pages 539-549

  Fujita, Rikiya ^a   Takahashi, Hiroshi ^a   Iwashige, Motohide ^a   Kamiyama, Tsukasa ^a   Hara, Hisato ^a   Koyama, Tsuneo ^a   Tomori, Akihisa ^a   Okaniwa, Shinji ^a   Masuyama, Hironori ^a   Mine, Tetsuya ^a   Tanaka, Shin ^a   Suzuki, Hidekazu ^a   Taguchi, Tadao ^a   Yarita, Tadashi ^a   Suzuki, Satoshi ^a   Nagai, Kozo ^a   Ohwaki, Tadashi ^a   Ohba, Ken ichi ^a   Kawai, Hiroki ^a   Murase, Ken ichi ^a   Ishimiya, Hiroshi ^a   Nagao, Toshihiro ^a   Komibuchi, Tomoo ^a   Yasutake, Koichi ^a   Shinagawa, Makoto ^a   Kawai, Kozo ^a   Inaba, Tomomi ^a   Kurinaga, Atsunobu ^a   Aoki, Hidetoshi ^a   Shibata, Yoko ^a   Fujimaru, Tatuya ^a   Kondo, Jun ^a   Nishima, Hiroyasu ^a   Kihara, Kosuke ^a   Kubo, Shigeru ^a   Sakumoto, Ken ^a   Miyahira, Morihiro ^a   Ohwan, Tomotsugu ^a   Shimajiri, Hiroto ^a   more..

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Advanced age patient; Peptic ulcer disease; Proton pump inhibitor; Rabeprazole; Special surveillance

Indexed keywords

PROTON PUMP INHIBITOR; RABEPRAZOLE;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; DUODENUM ULCER; EPIGASTRIC PAIN; GERIATRIC PATIENT; HEARTBURN; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; PEPTIC ULCER; REFLUX ESOPHAGITIS; STATISTICAL ANALYSIS; STOMACH ULCER; TABLET; ULCER HEALING; ZOLLINGER ELLISON SYNDROME;

EID: 0036032155     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Geriat Med 1994;32:891-6.
2. Prog Digest Endosc 1985; 26: 20-5.
3. Satoh K, et al. Relationship between Helicobacter pylori and atrophic gastritis. Eur J Gastroenterol Hepatol 1994; 6: S85-8.
4. Koike T, et al. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol 1999; 94: 3468-72.
5. Helicobacter Research 2001; 5: 24-9.
6. Williams MP, et al. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole 24-h intragastric acidity and plasma gastrin concentration in young healthy male subjects. Aliment Pharmacol Ther 1998; 12: 1079-89.
7. Ohning GV, et al. Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14: 701-8.
8. Geriat Med 1993; 31: 1121-4.